Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sinead Delany-Moretlwe, MBBCh, PhD, DTM&H
Wits RHI, University of The Witwatersrand
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Botswana Harvard Health Partnership
Gaborone, Botswana
- Ministry of Health and Center for Family Health Research
Kigali, Kigali, Rwanda
- Wits Rhi, University of the Witwatersrand
Johannesburg, Gauteng, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Oct 2024
- Primary completion
- 31 Dec 2026
- Completion
- 30 Jun 2027
- Last update posted
- 12 Jan 2026
- Registered enrollment
- 778
- Registry id
- NCT06436274
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.